These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27876779)

  • 1. Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants.
    Pastor V; Hirabayashi S; Karow A; Wehrle J; Kozyra EJ; Nienhold R; Ruzaike G; Lebrecht D; Yoshimi A; Niewisch M; Ripperger T; Göhring G; Baumann I; Schwarz S; Strahm B; Flotho C; Skoda RC; Niemeyer CM; Wlodarski MW
    Leukemia; 2017 Mar; 31(3):759-762. PubMed ID: 27876779
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Somatic and Germline Mutations in Myelodysplastic Syndromes and Related Disorders.
    Bejar R; Greenberg PL
    J Natl Compr Canc Netw; 2017 Jan; 15(1):131-135. PubMed ID: 28040723
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutation analysis of AML1 gene in pediatric primary myelodysplastic syndrome and juvenile myelomonocytic leukemia.
    Masunaga A; Mitsuya T; Kadofuku T; Iwamoto S; Miyazaki A; Manabe A; Zaike Y; Tsuchida M; Nakahata T
    Leuk Res; 2008 Jun; 32(6):995-7. PubMed ID: 17935781
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia.
    Yan B; Ng C; Moshi G; Ban K; Lee PL; Seah E; Chiu L; Koay ES; Liu TC; Ng CH; Chng WJ; Koh LP
    J Clin Pathol; 2016 Jul; 69(7):652-4. PubMed ID: 27010436
    [No Abstract]   [Full Text] [Related]  

  • 6. Germline variants drive myelodysplastic syndrome in young adults.
    Feurstein S; Churpek JE; Walsh T; Keel S; Hakkarainen M; Schroeder T; Germing U; Geyh S; Heuser M; Thol F; Pohlkamp C; Haferlach T; Gao J; Owen C; Goehring G; Schlegelberger B; Verma D; Krause DS; Gao G; Cronin T; Gulsuner S; Lee M; Pritchard CC; Subramanian HP; Del Gaudio D; Li Z; Das S; Kilpivaara O; Wartiovaara-Kautto U; Wang ES; Griffiths EA; Döhner K; Döhner H; King MC; Godley LA
    Leukemia; 2021 Aug; 35(8):2439-2444. PubMed ID: 33510405
    [No Abstract]   [Full Text] [Related]  

  • 7. Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome.
    Schwartz JR; Wang S; Ma J; Lamprecht T; Walsh M; Song G; Raimondi SC; Wu G; Walsh MF; McGee RB; Kesserwan C; Nichols KE; Cauff BE; Ribeiro RC; Wlodarski M; Klco JM
    Leukemia; 2017 Aug; 31(8):1827-1830. PubMed ID: 28487541
    [No Abstract]   [Full Text] [Related]  

  • 8. Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.
    Padron E; Ball MC; Teer JK; Painter JS; Yoder SJ; Zhang C; Zhang L; Moscinski LC; Rollison DE; Gore SD; Bejar R; Walter MJ; Sekeres MA; Komrokji RS; Epling-Burnette PK
    Blood; 2018 May; 131(21):2402-2405. PubMed ID: 29661788
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency.
    Ding LW; Ikezoe T; Tan KT; Mori M; Mayakonda A; Chien W; Lin DC; Jiang YY; Lill M; Yang H; Sun QY; Koeffler HP
    Leukemia; 2017 Jan; 31(1):244-245. PubMed ID: 27680514
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
    Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
    Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
    [No Abstract]   [Full Text] [Related]  

  • 11. Rare germline variant contributions to myeloid malignancy susceptibility.
    Li ST; Wang J; Wei R; Shi R; Adema V; Nagata Y; Kerr CM; Kuzmanovic T; Przychodzen B; Sole F; Maciejewski JP; LaFramboise T
    Leukemia; 2020 Jun; 34(6):1675-1678. PubMed ID: 31911633
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutational analysis of the neurofibromatosis type 1 gene in childhood myelodysplastic syndromes using a protein truncation assay.
    Side L
    Methods Mol Med; 2002; 68():157-70. PubMed ID: 11901500
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome.
    Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V
    Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of germline and somatic microlesion mutational spectra in 17 human tumor suppressor genes.
    Ivanov D; Hamby SE; Stenson PD; Phillips AD; Kehrer-Sawatzki H; Cooper DN; Chuzhanova N
    Hum Mutat; 2011 Jun; 32(6):620-32. PubMed ID: 21432943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
    Kozyra EJ; Göhring G; Hickstein DD; Calvo KR; DiNardo CD; Dworzak M; de Haas V; Starý J; Hasle H; Shimamura A; Fleming MD; Inaba H; Lewis S; Hsu AP; Holland SM; Arnold DE; Mecucci C; Keel SB; Bertuch AA; Tawana K; Barzilai S; Hirabayashi S; Onozawa M; Lei S; Alaiz H; Andrikovics H; Betts D; Beverloo BH; Buechner J; Čermák M; Cervera J; Haus O; Jahnukainen K; Manola KN; Nebral K; Pasquali F; Tchinda J; Turkiewicz D; Van Roy N; Zemanova Z; Pastor VB; Strahm B; Noellke P; Niemeyer CM; Schlegelberger B; Yoshimi A; Wlodarski MW
    Blood; 2021 Dec; 138(23):2441-2445. PubMed ID: 34469508
    [No Abstract]   [Full Text] [Related]  

  • 17. Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?
    Calvete O; Mestre J; Durmaz A; Gurnari C; Maciejewski JP; Solé F
    Br J Haematol; 2023 Apr; 201(1):e5-e11. PubMed ID: 36717968
    [No Abstract]   [Full Text] [Related]  

  • 18. Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies.
    Collado M; Landt O; Barragán E; Lass U; Cervera J; Sanz MA; Bolufer P
    Clin Chem; 2004 Nov; 50(11):2201-4. PubMed ID: 15502100
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome.
    Steinemann D; Praulich I; Otto N; Göhring G; Niemeyer CM; Schlegelberger B
    Br J Haematol; 2009 May; 145(4):533-4. PubMed ID: 19298594
    [No Abstract]   [Full Text] [Related]  

  • 20. Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.
    Moriyama T; Metzger ML; Wu G; Nishii R; Qian M; Devidas M; Yang W; Cheng C; Cao X; Quinn E; Raimondi S; Gastier-Foster JM; Raetz E; Larsen E; Martin PL; Bowman WP; Winick N; Komada Y; Wang S; Edmonson M; Xu H; Mardis E; Fulton R; Pui CH; Mullighan C; Evans WE; Zhang J; Hunger SP; Relling MV; Nichols KE; Loh ML; Yang JJ
    Lancet Oncol; 2015 Dec; 16(16):1659-66. PubMed ID: 26522332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.